Market regime: Neutral. Technical breakdown detected. Concerns: Price $34.69 is 4.2% below 150 MA ($36.21); Price $34.69 is 5.2% below 200 MA ($36.60); Poor MA alignment: 50 MA ($37.82), 150 MA ($36.21), 200 MA ($36.60)
Market regime: Neutral. Technical breakdown detected. Concerns: Price $34.08 is 6.0% below 150 MA ($36.24); Price $34.08 is 6.9% below 200 MA ($36.61); Poor MA alignment: 50 MA ($37.89), 150 MA ($36.24), 200 MA ($36.61)
Market regime: Neutral. Technical breakdown detected. Concerns: Price $33.98 is 6.3% below 150 MA ($36.25); Price $33.98 is 7.2% below 200 MA ($36.63); Poor MA alignment: 50 MA ($37.96), 150 MA ($36.25), 200 MA ($36.63)
Market regime: Neutral. Technical breakdown detected. Concerns: Poor MA alignment: 50 MA ($38.10), 150 MA ($36.30), 200 MA ($36.59); Sector weak - underperforming SPY by 5.7%; Price $36.97 is only 27.8% above 52-week low (needs >= 30%)
AI Evaluations last 3 months
1 records
Date
Price
Decision
Conf
Model
Rationale
05 Mar 2026
$36.97
HOLD
55%
claude-sonnet-4-6
Given the position was entered today at $36.41 with a stop at $33.50, the appropriate action is to HOLD and allow the trade time to develop rather than adding or exiting prematurely. The stock is maintaining support above its longer-term moving averages (SMA150, SMA200) while above-average volume could signal early accumulation, but the sub-SMA50 and sub-EMA21 price action and sector headwinds argue against adding conviction here. The RSI near 38 suggests the stock may be approaching a bounce zone, which aligns with the thesis for patient holding. The risk/reward from current levels ($37.97 current vs $33.50 stop) remains manageable, but the trade needs a recovery above $38.10–$38.47 (SMA50/EMA21) to confirm bullish momentum and justify higher confidence. Monitor the next earnings report date closely and watch China macro data as a key exogenous driver.
An error has occurred. This application may no longer respond until reloaded.
Reload🗙